Baylor scientists and others have searched for years to prove that a virus or other infection might explain why some get severe heart disease and others get none. A breakthrough in Finland, by Nobel Prize nominees Neva Ciftcioglu PhD and Olavi Kajander MD, PhD, has opened the door to a stunningly successful treatment program, now available locally.
Their discovery was an unsuspected, incredibly tiny bacterium-called Nanobacter-that appears to cause or worsen a variety of ailments, including heart disease. These tiny bacteria, seen only with powerful electron microscopes, "ooze" a protective shell of calcium, coating themselves just like the sugar glaze on a donut. When enough Nanobacter are present, specks of calcification appear and grow-hardening arteries, creating kidney stones, perhaps even cataracts and gum disease. Research is now underway at Mayo Clinic, Harvard, NASA, and other centers around the world.
Preliminary treatment trials have shown, within 6 months, decreases of 50% in heart artery calcifications, with dramatic improvements in symptoms, EKG tracings, and other tests. Also noted were better memory, more energy, return of sexual function, better physical performance, improved vision, even better hearing. Researchers saw lessening angina heart pains, lower blood pressure, better diabetes control, better circulation overall, even improvement in arthritis joint pains.
John Parks Trowbridge M.D., specialist in alternative approaches for over 20 years, sees this discovery as an exciting new choice in health care. Rather than just treating disease, people can choose to restore better health, reduce use of drugs dramatically, even avoid risks of surgery and hospital tests.
"Nanobacter treatment," explains Trowbridge, "is one of the last pieces in the puzzle of not just treating but even preventing heart disease, perhaps high blood pressure, and a whole host of other "degenerative" long-lasting diseases." Head of the Advanced Training Program in Heavy Metal Toxicology in 1996-1998 and a Fellow of the American College for Advancement in Medicine, Dr. Trowbridge pioneered development of an advanced chelation therapy program since 1993. "Nanobacter treatment," explains this author of 7 books including 3 on chelation as an effective method to remove unsuspected toxic metals contributing to heart and blood vessel diseases, "adds a dramatic new dimension to our efforts to return people to active, independent living."
Trowbridge has completed extensive revisions to incorporate Nanobacter treatment into his already advanced protocols. "Doctors without sufficient background in nutrition and toxic metal removal run the risk of needlessly creating new problems while trying to solve others," he cautions. "Our 20 years of experience produce safe and consistent results ...and adding treatments for the Nanobacter infections will be even more successful in meeting people's needs more quickly and with less expense, with the convenience that most of the treatment is done at home."
Finally feeling better, according to Dr. Trowbridge, has never been easier and never been more affordable. Insurance companies, he claims, have ignored many advances that help restore better health, programs that people would demand if they knew the real facts. "One reason that our advanced programs, and now Nanobacter treatments as well, are so wonderful is that they treat the causes of many problems, not just the discomforts.
People who come for help with 'heart disease' often brag about better digestion, fewer prostate problems or menopausal hot flashes, better sleep, fewer headaches, better skin tone, and on and on. We're thrilled to share in their successes and looking to help other who want the same."
This concept is highly controversial and may yet prove to be inaccurate. Further studies are needed.